2-Dec-2008
Subscription Info
|
Institutional Access
|
Browse the Faculties
|
Free Trial
|
Take a Tour
|
Top 10s
|
Advanced Search
|
Faculty Member List
|
About
Search
All F1000 Medicine
Oncology
Gynecological Ca...
Browse
ALL OF MEDICINE
Oncology
Breast Diseases: Benign & Malignant
Cancer in the Elderly
Genitourinary Cancers
Gynecological Cancers
Head & Neck Cancers
Oncology Agents
Pediatric Oncology
Sarcomas
Supportive & Palliative Cancer Care
Related Sections
Adrenal Cortex
Gastrointestinal Cancers
Leukemia & Proliferative Disorders of Hematic Cells
Lung Cancer
Lymphomas & Myelomas
Multiple Endocrine Disorders & Neoplasias
Neuro-Oncology
Skin Cancers (inc. Melanoma & Lymphoma)
selected for
My F1000 Medicine
Browse > Oncology > Gynecological Cancers
Current Top 10 by F1000 Factor
/
All Time Top 10 by F1000 Factor
/
Most viewed
(from all journals)
/
Most viewed
(from specialty journals)
/
Hidden jewels
Page 1 of 5. Select Page:
1
2
3
4
5
>>
Display
10
/
20
/
50
papers per page
printer friendly
10 per page
20 per page
50 per page
any date
past 7d
past 14d
past 30d
past 60d
past 90d
past 180d
past 1y
past 2y
past 5y
all papers
hypotheses
new findings
confirmations
tech advances
controversial
refutation
dissenting
new on F1000
newly evaluated
F1000 factor
most evaluations
this page
selected articles
to
EndNote
Ref. Manager
RefWorks
Bibtex
ProCite
email [
Help
]
Recommended
F1000 Factor
3.0
Confirmation
Controversial
Downregulation of XIAP expression in ovarian cancer cells induces cell death in vitro and in vivo.
Shaw TJ, Lacasse EC, Durkin JP, Vanderhyden BC
Int J Cancer
2008 Mar 15
122
(6):1430-4 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Carlos Telleria
Evaluated 11 Nov 2008
Must Read
F1000 Factor
4.8
Hypothesis
New Finding
Seeding and propagation of untransformed mouse mammary cells in the lung.
Podsypanina K, Du YC, …, Hambardzumyan D, Varmus H
Science
2008 Sep 26
321
(5897):1841-4 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Larry Suva / Christos Sotiriou with Michail Ignatiadis
First evaluation 7 Nov 2008 | Latest evaluation 11 Nov 2008
Exceptional
F1000 Factor
9.0
New Finding
A psychoeducational intervention for sexual dysfunction in women with gynecologic cancer.
Brotto LA, Heiman JR, …, Tamimi H, Van Blaricom A
Arch Sex Behav
2008 Apr
37
(2):317-29 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Stanley Althof with Rachel Needle
Evaluated 16 Oct 2008
Must Read
F1000 Factor
6.0
Confirmation
Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumour (PEComa): genetic evidence for the relationship of PEComa with angiomyolipoma.
Pan CC, Chung MY, …, Chen PC, Ho DM
J Pathol
2008 Feb
214
(3):387-93 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Joel Moss
Evaluated 8 Oct 2008
Must Read
F1000 Factor
6.0
Changes
Clinical Practice
Confirmation
New Finding
The role of secondary cytoreduction in the management of the first relapse in epithelial ovarian cancer.
Oksefjell H, Sandstad B, Tropé C
Ann Oncol
2008 Aug 25 [
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Philippe Van Trappen
Evaluated 6 Oct 2008
Recommended
F1000 Factor
3.0
Confirmation
New Finding
Vascular endothelial growth factor expression in ovarian cancer: a model for targeted use of novel therapies?
Duncan TJ, Al-Attar A, …, Spendlove I, Durrant LG
Clin Cancer Res
2008 May 15
14
(10):3030-5 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Jonathan Ledermann
Evaluated 2 Oct 2008
Recommended
F1000 Factor
3.0
New Finding
Phase II study of erlotinib in recurrent or metastatic endometrial cancer: NCIC IND-148.
Oza AM, Eisenhauer EA, …, Dancey J, Fyles A
J Clin Oncol
2008 Sep 10
26
(26):4319-25 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Maurie Markman
Evaluated 1 Oct 2008
Recommended
F1000 Factor
3.0
Confirmation
Prophylactic oophorectomy in premenopausal women and long-term health.
Shuster LT, Gostout BS, Grossardt BR, Rocca WA
Menopause Int
2008 Sep
14
(3):111-6 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| John Svigos with Alison Munt
Evaluated 23 Sep 2008
Must Read
F1000 Factor
6.0
New Finding
Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study.
Badawy A, Elnashar A, El-Ashry M, Shahat M
Fertil Steril
2008 Aug 1 [
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Michael Friedlander
Evaluated 4 Sep 2008
Must Read
F1000 Factor
6.0
New Finding
Classification of radical hysterectomy.
Querleu D, Morrow CP
Lancet Oncol
2008 Mar
9
(3):297-303 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Giovanni Scambia with Francesco Legge
Evaluated 1 Sep 2008
top of page
Page 1 of 5. Select Page:
1
2
3
4
5
>>
Display
10
/
20
/
50
papers per page
© 2008 Medicine Reports Ltd unless otherwise stated.
< info@f1000.com >
Terms and conditions
Legal info